pyridoxamine has been researched along with alloxan in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Elseweidy, MM; Elswefy, SE; Younis, NN; Zaghloul, MS | 1 |
1 other study(ies) available for pyridoxamine and alloxan
Article | Year |
---|---|
Pyridoxamine, an inhibitor of protein glycation, in relation to microalbuminuria and proinflammatory cytokines in experimental diabetic nephropathy.
Topics: Albuminuria; Alloxan; Animals; C-Reactive Protein; Cytokines; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Disease Models, Animal; Glycation End Products, Advanced; Interleukin-1alpha; Interleukin-6; Kidney; Male; Oxidative Stress; Pyridoxamine; Rats; Rats, Wistar; Transforming Growth Factor beta1; Tumor Necrosis Factor-alpha | 2013 |